Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Patients with bipolar disorder (BD) exhibit peripheral low-grade inflammation. The aim of the current study was to investigate the involvement of hitherto unexplored components of the tumor necrosis factor (TNF) superfamily in BD. Methods: Eighty patients with type I BD and 50 healthy controls matched for age and gender were enrolled in this study. All subjects were assessed with the Mini-Plus to evaluate psychiatric comorbidities; the Young Mania Rating Scale and the Hamilton Depression Rating Scale to evaluate manic and depressive symptoms severity, respectively. TNF superfamily molecules (TNF, TNF-related weak inducer of apoptosis [TWEAK], TNF-related apoptosis-inducing ligand [TRAIL], soluble TNF receptor type 1 [sTNFR1], and soluble TNF receptor type 2 [sTNFR2]) levels were measured by ELISA. Results: Patients with BD, regardless of mood state, presented increased plasma levels of sTNFR1 and TWEAK in comparison with controls. Conclusion: These findings corroborate the view that TNF superfamily may play a role in BD pathophysiology.
Abstract
Objective: Patients with bipolar disorder (BD) exhibit peripheral low-grade inflammation. The aim of the current study was to investigate the involvement of hitherto unexplored components of the tumor necrosis factor (TNF) superfamily in BD. Methods: Eighty patients with type I BD and 50 healthy controls matched for age and gender were enrolled in this study. All subjects were assessed with the Mini-Plus to evaluate psychiatric comorbidities; the Young Mania Rating Scale and the Hamilton Depression Rating Scale to evaluate manic and depressive symptoms severity, respectively. TNF superfamily molecules (TNF, TNF-related weak inducer of apoptosis [TWEAK], TNF-related apoptosis-inducing ligand [TRAIL], soluble TNF receptor type 1 [sTNFR1], and soluble TNF receptor type 2 [sTNFR2]) levels were measured by ELISA. Results: Patients with BD, regardless of mood state, presented increased plasma levels of sTNFR1 and TWEAK in comparison with controls. Conclusion: These findings corroborate the view that TNF superfamily may play a role in BD pathophysiology.
참고문헌 (26)
- Modabbernia A, "Cytokine alterations in bipolar disorder : a meta-analysis of 30studies", Biol Psychiatry, 74, pp.15~25 (2013)
- Munkholm K, "Cytokines in bipolar disorder vs. healthy control subjects:a systematic review and meta-analysis", J Psychiatr Res, 47, pp.1119~1133 (2013)
- Munkholm K, "Cytokines in bipolar disorder : a systematic review and meta-analysis", J Affect Disord, 144, pp.16~27 (2013)
- Teixeira AL, "Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment", Hum Psychopharmacol, 30, pp.52~56 (2015)
- Dean B, "Different changes in cortical tumor necrosis factor--related pathways in schizophrenia and mood disorders", Mol Psychiatry, 18, pp.767~773 (2013)
- Townsend JD, "Frontal-amygdala connectivity alterations during emotion downregulation in bipolar I disorder", Biol Psychiatry, 73, pp.127~135 (2013)
- Barbosa IG, "Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers", J Affect Disord, 137, pp.151~155 (2012)
- Barbosa IG, "Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder", Eur Arch Psychiatry Clin Neurosci, 261, pp.139~143 (2011)
- Maecker H, "TWEAK attenuates the transition from innate to adaptive immunity", Cell, 123, pp.931~944 (2005)
- Croft M, "The TNF family in T cell differentiation and function--unanswered questions and future directions", Semin Immunol, 26, pp.183~190 (2014)
- Cullen SP, "Fas and TRAIL 'death receptors' as initiators of inflammation : Implications for cancer", Semin Cell Dev Biol, 39, pp.26~34 (2015)
- Levandowski ML, "Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal", J Psychiatr Res, 53, pp.180~186 (2014)
- Mas S, "Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes", Diabetes, 59, pp.1292~1301 (2010)
- Wen J, "Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice", Brain Behav Immun, 54, pp.27~37 (2016)
- Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
- Young RC, "A rating scale for mania: reliability, validity and sensitivity", Br J Psychiatry, 133, pp.429~435 (1978)
- Hamilton M, "Development of a rating scale for primary depressive illness", Br J Soc Clin Psychol, 6, pp.278~296 (1967)
- Davis J, "Towards a classification of biomarkers of neuropsychiatric disease : from encompass to compass", Mol Psychiatry, 20, pp.152~153 (2015)
- Kapczinski F, "Peripheral biomarkers and illness activity in bipolar disorder", J Psychiatr Res, 45, pp.156~161 (2011)
- Berk M, "Stage managing bipolar disorder", Bipolar Disord, 16, pp.471~477 (2014)
- Barbosa IG, "Cytokines in bipolar disorder : paving the way for neuroprogression", Neural Plast, 2014, pp.360481~ (2014)
- Griffiths MR, "The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain", J Neuropathol Exp Neurol, 68, pp.217~226 (2009)
- Fiedorowicz JG, "Peripheral inflammation during abnormal mood states in bipolar I disorder", J Affect Disord, 187, pp.172~178 (2015)
- Pandey GN, "Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder", Bipolar Disord, 17, pp.636~644 (2015)
- Himmerich H, "Impact of antipsychotics on cytokine production in-vitro", J Psychiatr Res, 45, pp.1358~1365 (2011)
- Himmerich H, "Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro", J Psychiatr Res, 47, pp.1751~1759 (2013)